HypoGer: Comparison of Phenylephrine and Ephedrine in the Treatment of Hemodynamic Disorders After Spinal Anesthesia in the Elderly

Sponsor
Medical University of Warsaw (Other)
Overall Status
Unknown status
CT.gov ID
NCT03858465
Collaborator
(none)
50
1
2
14
3.6

Study Details

Study Description

Brief Summary

Spinal anesthesia is often used for lower limb surgery in elderly. Hypotension is a side effect of spinal block. In this study, intravenous ephedrine and phenylephrine will be compared with each other to prevent spinal anesthesia-induced hypotension, which is defined in absolute terms as a systolic blood pressure < 100 mmHg or in relative terms as a 20% fall of systolic blood pressure from baseline.

Detailed Description

Randomized single centre clinical randomized study will be performed on 50 participants. The inclusion criteria are participants (age more than 65 years) with proximal femoral fracture scheduled for lower limb surgery under spinal anesthesia.

The Ethics Committee approved this prospective study. Informed consent will be taken from individual subjects. Participants are randomly allocated into one of the two study groups.

Group A: participants who will receive intravenous 25 mg of ephedrine added to syringe with 50 ml 0,9% sodium chloride solution during 20 minutes. Group B: Phenylephrine 5 mg will be added to syringe with 50 ml 0,9% sodium chloride solution, participants will receive intravenous 0,3 mg of phenylephrine during 20 minutes. Randomization is achieved with the help of Random.org.

In order to reduce pain prior to spinal anesthesia an ultrasound-guided fascia iliaca block will be performed using a volume of 30 ml ropivacaine 0,2%. After skin infiltration with 3 ml of lidocaine, a 25G Pencan spinal needle will be inserted at the L3-L4 or L4-L5 vertebral interspaces. After aspirating cerebrospinal fluid, participants will receive hyperbaric bupivacaine 0.5% at 0,11 mg/cm according to the participant height. Ephedrine and phenylephrine will be given intravenous immediately after injection of bupivacaine. Impedance cardiography will be used to measure hemodynamic parameters: cardiac output, stroke volume, cardiac index, stroke index, systemic vascular resistance, systemic vascular resistance index. Heart rate, blood pressure and oxygen saturation will also be controlled. All these parameters will be measured and recorded every 5 minutes until 30 minutes after spinal anesthesia. The data will be statistically analyzed.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
50 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Prevention
Official Title:
Comparison of Phenylephrine and Ephedrine in the Treatment of Hemodynamic Disorders After Spinal Anesthesia in the Elderly
Actual Study Start Date :
Feb 1, 2019
Actual Primary Completion Date :
Feb 24, 2019
Anticipated Study Completion Date :
Apr 1, 2020

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: 25 mg of ephedrine

participants who will receive intravenous 1,25mg/min ephedrine during 20 minutes (total dosage is 25 mg of ephedrine).

Drug: Ephedrine
intravenous 25 mg of ephedrine
Other Names:
  • Ephedrinum hydrochloricum WZF Polfa Warszawa 25mg/ml
  • Active Comparator: 0,3 mg of phenylephrine

    participants who will receive intravenous 0,015mg/min phenylephrine during 20 minutes (total dosage is 0,3mg of phenylephrine).

    Drug: Phenylephrine
    intravenous 0,3 mg of phenylephrine
    Other Names:
  • Phenylephrine Unimedic 10mg/ml
  • Outcome Measures

    Primary Outcome Measures

    1. blood preasure (mean arterial pressure, systolic and diastolic blood pressure) [30 min]

      parameter will be measured and recorded every 5 min after spinal anesthesia.

    Secondary Outcome Measures

    1. heart rate, expressed in bpm [30 min]

      parameter will be measured using impedance cardiography and recorded every 5 min after spinal anesthesia.

    2. cardiac output, expressed in L/min [30 min]

      parameter will be measured using impedance cardiography and recorded every 5 min after spinal anesthesia.

    3. stroke volume, expressed in ml [30 min]

      parameter will be measured using impedance cardiography and recorded every 5 min after spinal anesthesia.

    4. cardiac index, expressed in L/min/m2, is the ratio of cardiac output to the body surface area. [30 min]

      parameter will be measured using impedance cardiography and recorded every 5 min after spinal anesthesia.

    5. stroke index, expressed in ml/m2, is the ratio of stroke volume to the body surface area. [30 min]

      parameter will be measured using impedance cardiography and recorded every 5 min after spinal anesthesia.

    6. systemic vascular resistance, expressed in Dynes.sec.cm-⁵ [30 min]

      parameter will be measured using impedance cardiography and recorded every 5 min after spinal anesthesia.

    7. systemic vascular resistance index, expressed in Dynes.sec.cm-⁵/m2, is the ratio of systemic vascular resistance to the body surface area. [30 min]

      parameter will be measured using impedance cardiography and recorded every 5 min after spinal anesthesia.

    8. stroke volume variation, expressed in percentage (%) [30 min]

      parameter will be measured using impedance cardiography and recorded every 5 min after spinal anesthesia.

    9. systemic oxygen delivery, expressed in ml/min [30 min]

      parameter will be measured using impedance cardiography and recorded every 5 min after spinal anesthesia.

    10. oxygen saturation, expressed in percentage (%) [30 min]

      parameter will be measured using pulse oximetry and recorded every 5 min after spinal anesthesia.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    65 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • elderly (age more than 65 years)

    • hip fracture scheduled for lower limb surgery under spinal anesthesia

    • spinal anesthesia

    Exclusion Criteria:
    • contraindications to spinal anesthesia

    • participant refusal

    • age less than 65

    • bradycardia (heart rate less than 60)

    • participants unable to give consent or inability to communicate

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Infant Jesus Teaching Hospital Warsaw Poland 02-005

    Sponsors and Collaborators

    • Medical University of Warsaw

    Investigators

    • Principal Investigator: Rafał Kowalczyk, PhD, I Department of Anaesthesiology and Intensive Care, Infant Jesus Teaching Hospital

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Rafal Kowalczyk, Principal Investigator, Medical University of Warsaw
    ClinicalTrials.gov Identifier:
    NCT03858465
    Other Study ID Numbers:
    • KB/129/2017
    First Posted:
    Feb 28, 2019
    Last Update Posted:
    Feb 28, 2019
    Last Verified:
    Feb 1, 2019
    Individual Participant Data (IPD) Sharing Statement:
    Undecided
    Plan to Share IPD:
    Undecided
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Product Manufactured in and Exported from the U.S.:
    No
    Keywords provided by Rafal Kowalczyk, Principal Investigator, Medical University of Warsaw
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Feb 28, 2019